Efficacy and safety of prolonged-release OROS methylphenidate in adults with attention deficit/hyperactivity disorder: A 13-week, randomized, double-blind, placebo-controlled, fixed-dose study

By Casas Miguel  

World Journal of Biological Psychiatry, Vol. 14, Iss. 4, 2013-05 ,pp. : 268-281

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, multicenter, Italian, comparative study versus zolmitriptan

By Allais Gianni   Tullo Vincenzo   Benedetto Chiara   Zava Dario   Omboni Stefano   Bussone Gennaro  

Neurological Sciences, Vol. 32, Iss. 1, 2011-05 ,pp. : 99-104

Springer Publishing Company

Access to resources Recommend Favorite

Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy

By Sharief M.   Viteri C.   Ben-Menachem E.   Weber M.   Reife R.   Pledger G.   Karim R.  

Epilepsy Research, Vol. 25, Iss. 3, 1996-11 ,pp. : 217-224

Elsevier

Access to resources Recommend Favorite

Seizure frequency and CSF parameters in a double-blind placebo controlled trial of gabapentin in patients with intractable complex partial seizures

By Pietka E.   H. K.H.   Ben-Menachem E.   Soderfelt B.   Hamberger A.   Hedner T.   Persson L.I.  

Epilepsy Research, Vol. 21, Iss. 3, 1995-07 ,pp. : 231-236

Elsevier

Access to resources Recommend Favorite

A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures

By Kalviainen R.   Brodie M.J.   Duncan J.   Chadwick D.   Edwards D.   Lyby K.   for the Northern European Tiagabine Study Group  

Epilepsy Research, Vol. 30, Iss. 1, 1998-03 ,pp. : 31-40

Elsevier

Access to resources Recommend Favorite